Diabetes Research and Clinical Practice
Volume 76, Issue 3 , Pages 390-396 , June 2007

Vascular phenotype and subclinical inflammation in diabetic Asian Indians without overt cardiovascular disease

  • A. Ray

      Affiliations

    • Vascular Medicine Unit, Department of Endocrinology and General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author at: Vascular Medicine Unit, Department of Endocrinology and General Internal Medicine, Leiden University Medical Center, P.O. Box 9600, C4, 2300 RC Leiden, The Netherlands. Tel.: +31 71 526 4680; fax: +31 71 524 8140.
    • ,
  • E.D. Beishuizen

      Affiliations

    • Vascular Medicine Unit, Department of Endocrinology and General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • A. Misra

      Affiliations

    • Department of Medicine, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • M.V. Huisman

      Affiliations

    • Vascular Medicine Unit, Department of Endocrinology and General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • J.T. Tamsma

      Affiliations

    • Vascular Medicine Unit, Department of Endocrinology and General Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands

Received 18 May 2006 ,Accepted 19 September 2006.

References 

  1. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ. 1991;302(6776):560–564
  2. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int. J. Obes. 2001;25(11):1722–1729
  3. Bongers I, Westendorp RG, Stolk B, Huysmans HA, Vandenbroucke JP. Early coronary heart disease together with type II diabetes mellitus in persons of Hindustani origin. Ned. Tijdschr. Geneeskd. 1995;139(1):16–18
  4. Middelkoop BJ, Kesarlal-Sadhoeram SM, Ramsaransing GN, Struben HW. Diabetes mellitus among South Asian inhabitants of The Hague: high prevalence and an age-specific socioeconomic gradient. Int. J. Epidemiol. 1999;28(6):1119–1123
  5. Beckles GL, Miller GJ, Kirkwood BR, Alexis SD, Carson DC, Byam NT. High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet. 1986;1(8493):1298–1301
  6. Anand SS, Razak F, Yi QL, Davis B, Jacobs R, Vuksan V, et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler. Thromb. Vasc. Biol. 2004;24(8):1509–1515
  7. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 2001;104(2):145–150
  8. Raji A, Gerhard-Herman MD, Warren M, Silverman SG, Raptopoulos V, Mantzoros CS, et al. Insulin resistance and vascular dysfunction in nondiabetic Asian Indians. J. Clin. Endocrinol. Metab. 2004;89(8):3965–3972
  9. Bhargava K, Hansa G, Bansal M, Tandon S, Kasliwal RR. Endothelium-dependent brachial artery flow mediated vasodilatation in patients with diabetes mellitus with and without coronary artery disease. J. Assoc. Physicians India. 2003;51:355–358
  10. Beishuizen ED, van de Ree MA, Jukema JW, Tamsma JT, van der Vijver JC, Meinders AE, et al. Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes Care. 2004;27(12):2887–2892
  11. Beishuizen ED, Jukema JW, Tamsma JT, van de Ree MA, van der Vijver JC, Putter H, et al. No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes Care. 2005;28(7):1675–1679
  12. Beishuizen ED, Tamsma JT, Jukema JW, van de Ree MA, van der Vijver JC, Meinders AE, et al. The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease. Diabetes Care. 2005;28(7):1668–1674
  13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18(6):499–502
  14. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin. Sci. (Lond.). 2001;101(6):671–679
  15. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998;15(7):539–553
  16. Balkau B, Charles MA European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report from the WHO consultation. Diabet. Med. 1999;16(5):442–443
  17. Chandie Shaw PK, van Es LA, Paul LC, Rosendaal FR, Souverijn JH, Vandenbroucke JP. Renal disease in relatives of Indo-Asian type 2 diabetic patients with end-stage diabetic nephropathy. Diabetologia. 2003;46(5):618–624
  18. Anand SS, Enas EA, Pogue J, Haffner S, Pearson T, Yusuf S. Elevated lipoprotein(a) levels in South Asians in North America. Metabolism. 1998;47(2):182–184
  19. Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians. Heart. 1999;81(5):501–504
  20. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation. 2004;109(16):1955–1959
  21. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int. J. Obes. Relat. Metab. Disord. 2001;25(9):1327–1331
  22. Chatha K, Anderson NR, Gama R. Ethnic variation in C-reactive protein: UK resident Indo-Asians compared with Caucasians. J. Cardiovasc. Risk. 2002;9(3):139–141
  23. Mohan V, Deepa R, Velmurugan K, Premalatha G. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6). Diabet. Med. 2005;22(7):863–870
  24. Dudeja V, Misra A, Pandey RM, Devina G, Kumar G, Vikram NK. BMI does not accurately predict overweight in Asian Indians in northern India. Br. J. Nutr. 2001;86(1):105–112
  25. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J. Clin. Endocrinol. Metab. 1999;84(1):137–144
  26. Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in asian Indian adults. Diabetes Care. 2003;26(5):1380–1384
  27. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96(5):1432–1437
  28. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N. Engl. J. Med. 1999;340(1):14–22
  29. Snehalatha C, Vijay V, Mohan RS, Satyavani K, Sivasankari S, Megha T, et al. Lack of association of insulin resistance and carotid intimal medial thickness in non-diabetic Asian Indian subjects. Diabetes Metab. Res. Rev. 2001;17(6):444–447
  30. Rema M, Mohan V, Deepa R, Ravikumar R. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: The Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care. 2004;27(8):1962–1967

PII: S0168-8227(06)00427-X

doi: 10.1016/j.diabres.2006.09.021

Diabetes Research and Clinical Practice
Volume 76, Issue 3 , Pages 390-396 , June 2007

Article Tools